This contract is awarded for the ongoing supply of the medication "Axicabtagen Ciloleucel" under the Framework Agreement for the Health Area of A Coruña and Cee. Suppliers are invited to provide this specific antineoplastic agent, which is crucial for cancer treatment. The contract is managed by the
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, CORUA AND CEE HEALTH AREA GALICIAN HEALTH SERVICE has awarded 8 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the ongoing supply of the medication Axicabtagen Ciloleucel for the Health Area of A Coruña and Cee. The contract is awarded based on a framework agreement and is intended to ensure that this essential medication is available for patients in need. Suppliers interested in this
This contract is for the ongoing supply of the medication "Axicabtagen Ciloleucel" under a framework agreement. The contract is awarded to support the Health Area of A Coruña and Cee, ensuring that healthcare providers have access to this essential treatment. Suppliers interested in this opportunity
The Galician Health Service is seeking suppliers for the ongoing provision of long-term implantable left ventricular assist devices. These devices are essential for the cardiology and cardiac surgery services across various healthcare areas within the Galician Health Service. Suppliers should be pre
This contract involves the ongoing supply of bread, its derivatives, and cold cuts for various hospital centers within the Health Area of A Coruña and Cee. The total value of the contract is approximately €678,082.90. Suppliers are invited to provide these essential food products to support hospital
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
MMUH seeks a dermatology service provider to help meet increased demand for dermatological care through outsourced clinical services.
Market engagement opportunity to provide input on capillary blood sampling device requirements for HSCNI Trusts; questionnaire submissions due by 14th November 2026.
Hull City Council seeks to award a £187,500 Drug and Alcohol Treatment and Recovery services contract from November 2026 to March 2029 via direct award; providers must submit representations by 27 October 2026.
